As of October 31, manufacturers of veterinary biotech drugs will be held to new, strict standards on labeling. Although companies will have between four and six years to comply, the changes will ultimately help clarify treatment risks and benefits for veterinarians, pet owners and food producers.
In the past, the labels of vaccines and other biotechnology drugs for animals only had to describe the approved indications, according to the Journal of the American Veterinary Medical Association (JAVMA). Once the rule change has been implemented, those labels will include many more details, such as vaccination schedules, routes of administration and the minimum age of the animals targeted for treatment, according to the USDA. Some labels will also include pregnancy and fetal health risks.
Well it's about time is all we can say. The pet health industry is vastly different than the human industry. Which was understandable many years ago, but we have the technology and resources today to treat animals with the same pride and respect. Pets have the same receptors as humans allowing the rebound effect of LDN to help them the same way it helps us. It will balance their immune system and has been know to fight many types of cancers, tumors, weight loss, and many unknown problems. If you wouldn't give your self the drug, then why should your dog take it. LDN for you and your pet, thats the real winner.